Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (open in new tab).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-PANTOPRAZOLE T MYLAN PHARMACEUTICALS ULC Resolved 40MG Updated Report 2026-03-06 275166
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP BAXTER CORPORATION Resolved 450MG 5G 150MG Updated Report 2026-03-06 278883
VIAGRA BGP PHARMA ULC Actual shortage 50MG New Report 2026-03-05 278843
VORICONAZOLE FOR INJECTION SANDOZ CANADA INCORPORATED Actual shortage 200MG Updated Report 2026-03-05 277665
ZESTORETIC SEARCHLIGHT PHARMA INC Actual shortage 25MG 20MG Updated Report 2026-03-05 277421
ZESTORETIC SEARCHLIGHT PHARMA INC Actual shortage 12.5MG 20MG Updated Report 2026-03-05 277418
VISIONBLUE DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV Actual shortage 0.06% Updated Report 2026-03-05 276273
VIAGRA BGP PHARMA ULC Actual shortage 25MG Updated Report 2026-03-05 275983
VITAMIN K1 SANDOZ CANADA INCORPORATED Actual shortage 2MG Updated Report 2026-03-05 275891
YASMIN 28 BAYER INC Actual shortage 3MG 0.03MG Updated Report 2026-03-05 275189

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
ZENHALE ORGANON CANADA INC. Discontinued 200MCG 5MCG Updated Report 2026-03-05 262162
BENZAMYCIN BAUSCH HEALTH, CANADA INC. Discontinued 3% 5% Updated Report 2026-03-05 276371
20% PROSOL BAXTER CORPORATION To be discontinued 1.34G 1.35G 0.98G 0.32G 0.76G 0.6G 1.02G 1G 2.06G 1.08G 1.44G 2.76G 1.08G 1.02G 1.96G 0.05G 1.18G New Report 2026-02-27 278886
SANDOZ MONTELUKAST SANDOZ CANADA INCORPORATED Discontinued 4MG New Report 2026-02-23 278699
SANTYL SMITH & NEPHEW INC Discontinued 250UNIT New Report 2026-02-23 278673
Get it on Google Play Download on the App Store